Gene Biotherapeutics, Inc. (CRXM)

USD 0.0

(9900.0%)

Gross Profit Summary of Gene Biotherapeutics, Inc.

  • Gene Biotherapeutics, Inc.'s latest annual gross profit in 2022 was - USD , down 0.0% from previous year.
  • Gene Biotherapeutics, Inc.'s latest quarterly gross profit in 2022 FY was - USD , down 0.0% from previous quarter.
  • Gene Biotherapeutics, Inc. reported a annual gross profit of - USD in annual gross profit 2021, up 100.0% from previous year.
  • Gene Biotherapeutics, Inc. reported a annual gross profit of -1816.00 USD in annual gross profit 2020, up 96.88% from previous year.
  • Gene Biotherapeutics, Inc. reported a quarterly gross profit of - USD for 2021 FY, up 100.0% from previous quarter.
  • Gene Biotherapeutics, Inc. reported a quarterly gross profit of - USD for 2020 Q1, down 0.0% from previous quarter.

Annual Gross Profit Chart of Gene Biotherapeutics, Inc. (2022 - 1995)

Historical Annual Gross Profit of Gene Biotherapeutics, Inc. (2022 - 1995)

Year Gross Profit Gross Profit Growth
2022 - USD 0.0%
2021 - USD 100.0%
2020 -1816.00 USD 96.88%
2019 -58.17 Thousand USD 7.95%
2018 -63.2 Thousand USD 4.37%
2017 -66.08 Thousand USD -230.01%
2016 -20.02 Thousand USD -102.51%
2015 -9889.00 USD 0.0%
2014 - USD -100.0%
2013 40.04 Thousand USD -88.5%
2012 348.25 Thousand USD 0.0%
2011 - USD -100.0%
2010 244.47 Thousand USD -45.05%
2009 444.94 Thousand USD -54.86%
2008 985.81 Thousand USD 313.89%
2007 238.18 Thousand USD 220.26%
2006 -198.05 Thousand USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD -100.0%
1998 4.55 Million USD 34.26%
1997 3.39 Million USD 438.03%
1996 630.48 Thousand USD 64.98%
1995 382.15 Thousand USD 0.0%

Peer Gross Profit Comparison of Gene Biotherapeutics, Inc.

Name Gross Profit Gross Profit Difference
America Great Health 168.58 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. -250 Thousand USD 100.0%
Aridis Pharmaceuticals, Inc. - USD NaN%
Biora Therapeutics, Inc. -551 Thousand USD 100.0%
Bio-Path Holdings, Inc. -178 Thousand USD 100.0%
Better Therapeutics, Inc. -2.72 Million USD 100.0%
Calithera Biosciences, Inc. -1.38 Million USD 100.0%
Comera Life Sciences Holdings, Inc. 422.71 Thousand USD 100.0%
eFFECTOR Therapeutics, Inc. -22.91 Million USD 100.0%
Eloxx Pharmaceuticals, Inc. - USD NaN%
Evelo Biosciences, Inc. - USD NaN%
Evolutionary Genomics, Inc. -1.02 Million USD 100.0%
Finch Therapeutics Group, Inc. -7.09 Million USD 100.0%
Galera Therapeutics, Inc. -259 Thousand USD 100.0%
Innovation1 Biotech Inc. -52.69 Thousand USD 100.0%
Kiromic BioPharma, Inc. -2.79 Million USD 100.0%
Molecular Templates, Inc. 50.39 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD 100.0%
NexImmune, Inc. -1.02 Million USD 100.0%
Orgenesis Inc. -5.72 Million USD 100.0%
Panbela Therapeutics, Inc. -25.64 Million USD 100.0%
Point of Care Nano-Technology, Inc. -4601.00 USD 100.0%
PaxMedica, Inc. Common Stock - USD NaN%
Scopus BioPharma Inc. - USD NaN%
Sorrento Therapeutics, Inc. 29.38 Million USD 100.0%
Statera Biopharma, Inc. -488.31 Thousand USD 100.0%
TRACON Pharmaceuticals, Inc. -232 Thousand USD 100.0%
Trevena, Inc. 1.45 Million USD 100.0%
Vaxxinity, Inc. -2.23 Million USD 100.0%
Vaccinex, Inc. -16 Million USD 100.0%
Vicapsys Life Sciences, Inc. - USD NaN%
Viracta Therapeutics, Inc. -492 Thousand USD 100.0%
ZIVO Bioscience, Inc. 11.61 Thousand USD 100.0%